—The exact pathology of tardive dyskinesia is still unclear, but the potential genetic factors these investigators have identified may enhance the understanding, treatment, and prevention of this ...
MinnPost’s reporting is always free, but it isn’t free to produce. We rely on donations from our readers to fund our independent journalism. The Center for Racial and Health Equity generously supports ...
The mechanisms for secretion or excretion of sHLA class I and II in various human body fluids remain unknown. It has been suggested that liver cells and activated immunocompetent cells actively ...
Graft vs. host disease (GVHD) can occur after a stem cell transplant from a donor. Transplants replace unhealthy cells with healthy blood-forming cells, which can treat some cancers. GVHD happens when ...
The correlation between mutation burden and disease free survival in patients with lung adenocarcinomas. Expansion study of ADI-PEG 20, pemetrexed and cisplatin in patients with ASS1-deficient ...
SOUTH SAN FRANCISCO, Calif., October 06, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company ™ – a leading precision medicine company focused on the discovery, development, and ...